Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the use in the prospectus constituting a part of this Post-Effective Amendment No. 2 to Registration Statement on Form S-1 (No. 333-166531), of our report dated March 25, 2011, except for Note 15, as to which the date is December 21, 2011, relating to the consolidated financial statements of Titan Pharmaceuticals, Inc. appearing in the Annual Report on Form 10-K of Titan Pharmaceuticals, Inc. for the year ended December 31, 2010.
We also consent to the reference to us under the caption Experts in the prospectus.
/s/ ODENBERG, ULLAKKO, MURANISHI & CO. LLP
San Francisco, California
December 21, 2011